Abstract
Astrocytes are important glial cells involved in the ionic regulation of the extracellular fluid in the Central Nervous System (CNS), the formation of the blood brain barrier (BBB) and the support to neurons for the maintenance of the Krebs cycle intermediaries. Even though these cells are known to be important for the brain functioning, several of their functions and their development have not been fully elucidated. In this context, identifying the algorithms used for their analysis plays a pivotal role in the development of new strategies in the study of astrocytes. The main objective of this review is to summarize the techniques that have helped to obtain transcriptomic data in astrocytes and the new algorithms that were used to perform the analysis of experimental data, elucidating new studies in which these had been used. We also highlight the current transcriptomics approaches targeting astrocytes function as a possible target for pharmacological interventions.
Keywords: Astrocytes, transcriptome methods, brain, neurological disorders, central nervous system, blood brain barrier.
Current Pharmaceutical Design
Title:Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets
Volume: 23 Issue: 28
Author(s): George E. Barreto *, Rosa M. Gomez, Rosa Helena Bustos, Diego A. Forero, Gjumrakch Aliev, Vadim V. Tarasov, Nagendra S. Yarla, Valentina Echeverria and Janneth Gonzalez
Affiliation:
- Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C,Colombia
Keywords: Astrocytes, transcriptome methods, brain, neurological disorders, central nervous system, blood brain barrier.
Abstract: Astrocytes are important glial cells involved in the ionic regulation of the extracellular fluid in the Central Nervous System (CNS), the formation of the blood brain barrier (BBB) and the support to neurons for the maintenance of the Krebs cycle intermediaries. Even though these cells are known to be important for the brain functioning, several of their functions and their development have not been fully elucidated. In this context, identifying the algorithms used for their analysis plays a pivotal role in the development of new strategies in the study of astrocytes. The main objective of this review is to summarize the techniques that have helped to obtain transcriptomic data in astrocytes and the new algorithms that were used to perform the analysis of experimental data, elucidating new studies in which these had been used. We also highlight the current transcriptomics approaches targeting astrocytes function as a possible target for pharmacological interventions.
Export Options
About this article
Cite this article as:
Barreto E. George *, Gomez M. Rosa, Bustos Helena Rosa , Forero A. Diego , Aliev Gjumrakch , Tarasov V. Vadim , Yarla S. Nagendra , Echeverria Valentina and Gonzalez Janneth , Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets, Current Pharmaceutical Design 2017; 23 (28) . https://dx.doi.org/10.2174/1381612823666170406113501
DOI https://dx.doi.org/10.2174/1381612823666170406113501 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Left Anterior Temporal Lobe Sustains Naming in Alzheimers Dementia and Mild Cognitive Impairment
Current Alzheimer Research FMRI and Multiple Sclerosis
Current Medical Imaging Borderline Personality Disorder in Young People and the Prospects for Prevention and Early Intervention
Current Psychiatry Reviews HSP22 and its Role in Human Neurological Disease
Current Neurovascular Research An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis
Medicinal Chemistry Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology The Ambivalence of Early Diagnosis – Returning Results in Current Alzheimer Research
Current Alzheimer Research Matrix Metalloproteinases and their Tissue Inhibitors in Diabetes, Atherosclerosis and Prediction of the Cardiovascular Risk
Current Enzyme Inhibition Modulation of Protein Metabolism to Mitigate Nitrous Oxide (N2O) Emission from Excreta of Livestock
Current Protein & Peptide Science Cognitive Impact of Cerebellar Damage: Is There a Future for Cognitive Rehabilitation?
CNS & Neurological Disorders - Drug Targets Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Therapeutic Relevance of the Allosteric Modulation of the 5-HT Transporter
Current Signal Transduction Therapy Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Lipid Based Nanosystems for Curcumin: Past, Present and Future
Current Pharmaceutical Design High Frequency of the Opioid Receptor µ-1 (OPRM1) A118G Polymorphism, an Opioid Drug Therapy Related Gene, in the Indonesian Population
Current Pharmacogenomics and Personalized Medicine Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design 3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease
Current Drug Targets - CNS & Neurological Disorders Transcription Factors as Therapeutic Targets in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued)